| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.UROLOGY.2010.11.002 |
| P698 | PubMed publication ID | 21296393 |
| P50 | author | Eiji Kikuchi | Q48851334 |
| Nobuyuki Tanaka | Q64008584 | ||
| Mototsugu Oya | Q89427182 | ||
| P2093 | author name string | Takeo Kosaka | |
| Takahiro Maeda | |||
| Akira Miyajima | |||
| Suguru Shirotake | |||
| P2860 | cites work | Angiogenesis in cancer and other diseases | Q27861015 |
| Cancer statistics, 2009 | Q29547625 | ||
| Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma | Q34570747 | ||
| Do inhibitors of angiotensin-I-converting enzyme protect against risk of cancer? | Q34749837 | ||
| Renin and angiotensinogen expression and functions in growth and apoptosis of human glioblastoma | Q36694665 | ||
| EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder | Q37158767 | ||
| Hypoxia-induced pathological angiogenesis mediates tumor cell dissemination, invasion, and metastasis in a zebrafish tumor model | Q37428993 | ||
| Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy | Q37540810 | ||
| Cis-dichlorodiammineplatinum upregulates angiotensin II type 1 receptors through reactive oxygen species generation and enhances VEGF production in bladder cancer. | Q39639537 | ||
| Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth | Q39778121 | ||
| Effect of angiotensin II type 1 receptor antagonist on tumor growth and angiogenesis in a xenograft model of human bladder cancer | Q40132288 | ||
| Angiotensin II type 1 receptor antagonist as an angiogenic inhibitor in prostate cancer | Q40219744 | ||
| Angiotensin II type 1 receptor antagonist candesartan as an angiogenic inhibitor in a xenograft model of bladder cancer. | Q40283559 | ||
| Vascular endothelial growth factor: an important angiogenic mediator in bladder cancer | Q40825351 | ||
| Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis | Q44018962 | ||
| Activation of invasiveness of cervical carcinoma cells by angiotensin II. | Q44914083 | ||
| Angiogenesis in bladder cancer: relationship between microvessel density and tumor prognosis | Q46425047 | ||
| Neovascularisation is a prognostic factor of early recurrence in T1/G2 urothelial bladder tumours. | Q51018904 | ||
| Association of Angiogenesis Related Markers With Bladder Cancer Outcomes and Other Molecular Markers | Q59649562 | ||
| The effect of intravesical mitomycin C on recurrence of newly diagnosed superficial bladder cancer: a further report with 7 years of follow up | Q71083101 | ||
| Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist | Q73832450 | ||
| Angiogenic switch of angiopietins-Tie2 system and its prognostic value in bladder cancer | Q82994795 | ||
| P433 | issue | 4 | |
| P921 | main subject | microvessel | Q6840468 |
| P304 | page(s) | 1009.e19-25 | |
| P577 | publication date | 2011-02-05 | |
| P1433 | published in | Urology | Q7900884 |
| P1476 | title | Angiotensin II type 1 receptor expression and microvessel density in human bladder cancer | |
| P478 | volume | 77 |
| Q93018069 | (Pro)renin Receptor Expression Increases throughout the Colorectal Adenoma-Adenocarcinoma Sequence and It Is Associated with Worse Colorectal Cancer Prognosis |
| Q44636285 | A Mini-Review of Reactive Oxygen Species in Urological Cancer: Correlation with NADPH Oxidases, Angiogenesis, and Apoptosis |
| Q36224953 | Angiogenesis in upper tract urothelial carcinoma associated with Balkan endemic nephropathy. |
| Q104752919 | Angiotensin II receptor blockers valsartan and losartan improve survival rate clinically and suppress tumor growth via apoptosis related to PI3K/AKT signaling in nasopharyngeal carcinoma |
| Q33784943 | Angiotensin II type 2 receptor promotes apoptosis and inhibits angiogenesis in bladder cancer |
| Q37687136 | Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activation |
| Q83500366 | Antihypertensive medications are associated with the risk of kidney and bladder cancer: a systematic review and meta-analysis |
| Q37434424 | Expression and clinical significance of angiotensin II type 1 receptor in human hepatocellular carcinoma |
| Q36214638 | Involvement of angiotensin II type 2 receptor (AT2R) signaling in human pancreatic ductal adenocarcinoma (PDAC): a novel AT2R agonist effectively attenuates growth of PDAC grafts in mice. |
| Q26774965 | Predictive Markers for the Recurrence of Nonmuscle Invasive Bladder Cancer Treated with Intravesical Therapy |
| Q59125636 | Renin-angiotensin inhibitors reprogram tumor immune microenvironment: A comprehensive view of the influences on anti-tumor immunity |
| Q47863448 | Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy. |
| Q41418421 | The prognostic significance of vasohibin-1 expression in patients with prostate cancer |
Search more.